Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Chronic Obstructive Pulmonary Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Obstructive Pulmonary Diseasemarket, defines the market attractiveness level of Chronic Obstructive Pulmonary Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chronic Obstructive Pulmonary Disease industry, describes the types of Chronic Obstructive Pulmonary Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Obstructive Pulmonary Disease market and the development prospects and opportunities of Chronic Obstructive Pulmonary Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Obstructive Pulmonary Disease market in Chapter 13.
By Player:
Roche Group
Boehringer Ingelheim
Jubilant Pharma Limited
Novartis
Pfizer
Sunovion
Horizon Pharma
Almirall
AstraZeneca
MSD
GSK
By Type:
Bronchodilators
Glucocorticoids
Other
By End-User:
Prevention
Diagnostic
Treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chronic Obstructive Pulmonary Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chronic Obstructive Pulmonary Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chronic Obstructive Pulmonary Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chronic Obstructive Pulmonary Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chronic Obstructive Pulmonary Disease Market Analysis and Outlook to 2022
-
7.1 Global Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
-
7.2 United States Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
-
7.3 Europe Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
-
7.4 China Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
-
7.5 Japan Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
-
7.6 India Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
-
7.7 South Korea Chronic Obstructive Pulmonary Disease Consumption (2017-2022)
8 Region and Country-wise Chronic Obstructive Pulmonary Disease Market Analysis and Outlook to 2028
-
8.1 Global Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
-
8.2 United States Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
-
8.3 Europe Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
-
8.4 China Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
-
8.5 Japan Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
-
8.6 India Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Chronic Obstructive Pulmonary Disease Consumption Forecast (2022-2028)
9 Global Chronic Obstructive Pulmonary Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Chronic Obstructive Pulmonary Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Glucocorticoids Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Chronic Obstructive Pulmonary Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Prevention Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Treatment Consumption and Growth Rate (2017-2022)
10 Global Chronic Obstructive Pulmonary Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Glucocorticoids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Prevention Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Chronic Obstructive Pulmonary Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chronic Obstructive Pulmonary Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chronic Obstructive Pulmonary Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chronic Obstructive Pulmonary Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chronic Obstructive Pulmonary Disease Market Competitive Analysis
-
14.1 Roche Group
-
14.1.1 Roche Group Company Details
-
14.1.2 Roche Group Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Group Chronic Obstructive Pulmonary Disease Product and Service
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Details
-
14.2.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product and Service
-
14.3 Jubilant Pharma Limited
-
14.3.1 Jubilant Pharma Limited Company Details
-
14.3.2 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Chronic Obstructive Pulmonary Disease Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Chronic Obstructive Pulmonary Disease Product and Service
-
14.6 Sunovion
-
14.6.1 Sunovion Company Details
-
14.6.2 Sunovion Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sunovion Chronic Obstructive Pulmonary Disease Product and Service
-
14.7 Horizon Pharma
-
14.7.1 Horizon Pharma Company Details
-
14.7.2 Horizon Pharma Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Product and Service
-
14.8 Almirall
-
14.8.1 Almirall Company Details
-
14.8.2 Almirall Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Almirall Chronic Obstructive Pulmonary Disease Product and Service
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Details
-
14.9.2 AstraZeneca Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AstraZeneca Chronic Obstructive Pulmonary Disease Product and Service
-
14.10 MSD
-
14.10.1 MSD Company Details
-
14.10.2 MSD Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 MSD Chronic Obstructive Pulmonary Disease Product and Service
-
14.11 GSK
-
14.11.1 GSK Company Details
-
14.11.2 GSK Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GSK Chronic Obstructive Pulmonary Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chronic Obstructive Pulmonary Disease
-
Figure Chronic Obstructive Pulmonary Disease Picture
-
Table Global Chronic Obstructive Pulmonary Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Obstructive Pulmonary Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Obstructive Pulmonary Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chronic Obstructive Pulmonary Disease Consumption by Country (2017-2022)
-
Figure United States Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure China Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure India Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Obstructive Pulmonary Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Glucocorticoids Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Prevention Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glucocorticoids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prevention Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chronic Obstructive Pulmonary Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chronic Obstructive Pulmonary Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche Group (Foundation Year, Company Profile and etc.)
-
Table Roche Group Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Group Chronic Obstructive Pulmonary Disease Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product and Service
-
Table Jubilant Pharma Limited (Foundation Year, Company Profile and etc.)
-
Table Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Chronic Obstructive Pulmonary Disease Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Chronic Obstructive Pulmonary Disease Product and Service
-
Table Sunovion (Foundation Year, Company Profile and etc.)
-
Table Sunovion Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Chronic Obstructive Pulmonary Disease Product and Service
-
Table Horizon Pharma (Foundation Year, Company Profile and etc.)
-
Table Horizon Pharma Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma Chronic Obstructive Pulmonary Disease Product and Service
-
Table Almirall (Foundation Year, Company Profile and etc.)
-
Table Almirall Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almirall Chronic Obstructive Pulmonary Disease Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Chronic Obstructive Pulmonary Disease Product and Service
-
Table MSD (Foundation Year, Company Profile and etc.)
-
Table MSD Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table MSD Chronic Obstructive Pulmonary Disease Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Chronic Obstructive Pulmonary Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Chronic Obstructive Pulmonary Disease Product and Service
-
